Dr. Barry Dworkin

New monoclonal antibodies designed to stop Epstein Barr virus from attaching to and entering human immune cells

Medical Mythbusting Commentary for April 16, 2026

Source:
95% of people carry this virus and scientists may have just found how to stop it

Reference:
Transgenic mouse-derived human monoclonal antibodies targeting EBV gp350 and gp42 provide basis for therapeutic development.

Related posts:

  1. Vaccine implant destroys cancer tumours in mice
  2. Pancreatic cancer research given a boost
  3. New biotherapeutic cancer treatment centre an excellent addition to novel therapeutic solutions
  4. Tweaking CAR-T activity with on/off switches may reduce cytokine release syndrome.